Patents by Inventor John Baxter Biggins

John Baxter Biggins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human Therapeutic Targets and Modulators Thereof
    Publication number: 20260011401
    Abstract: Among other things, the present disclosure provides technologies for efficient and effective identification of ETaGs, for example, from fungi genomes. In some embodiments, provided technologies are particularly useful for identifying mammalian targets of biosynthetic products of fungi. In some embodiments, provided technologies are particularly useful for identifying and/or prioritizing human targets for drug development. In some embodiments, provided technologies are particularly useful for developing modulators for human targets based on biosynthetic products of fungi.
    Type: Application
    Filed: January 29, 2025
    Publication date: January 8, 2026
    Inventors: John Baxter BIGGINS, Brian Roger BOWMAN, Gregory L. VERDINE
  • Human therapeutic targets and modulators thereof
    Patent number: 12243623
    Abstract: Among other things, the present disclosure provides technologies for efficient and effective identification of ETaGs, for example, from fungi genomes. In some embodiments, provided technologies are particularly useful for identifying mammalian targets of biosynthetic products of fungi. In some embodiments, provided technologies are particularly useful for identifying and/or prioritizing human targets for drug development. In some embodiments, provided technologies are particularly useful for developing modulators for human targets based on biosynthetic products of fungi.
    Type: Grant
    Filed: July 13, 2023
    Date of Patent: March 4, 2025
    Assignee: LifeMine Therapeutics, Inc.
    Inventors: John Baxter Biggins, Brian Roger Bowman, Gregory L. Verdine
  • HUMAN THERAPEUTIC TARGETS AND MODULATORS THEREOF
    Publication number: 20240212788
    Abstract: Among other things, the present disclosure provides technologies for efficient and effective identification of ETaGs, for example, from fungi genomes. In some embodiments, provided technologies are particularly useful for identifying mammalian targets of biosynthetic products of fungi. In some embodiments, provided technologies are particularly useful for identifying and/or prioritizing human targets for drug development. In some embodiments, provided technologies are particularly useful for developing modulators for human targets based on biosynthetic products of fungi.
    Type: Application
    Filed: July 13, 2023
    Publication date: June 27, 2024
    Inventors: John Baxter BIGGINS, Brian Roger BOWMAN, Gregory L. VERDINE
  • Human therapeutic targets and modulators thereof
    Patent number: 11749375
    Abstract: Among other things, the present disclosure provides technologies for efficient and effective identification of ETaGs, for example, from fungi genomes. In some embodiments, provided technologies are particularly useful for identifying mammalian targets of biosynthetic products of fungi. In some embodiments, provided technologies are particularly useful for identifying and/or prioritizing human targets for drug development. In some embodiments, provided technologies are particularly useful for developing modulators for human targets based on biosynthetic products of fungi.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: September 5, 2023
    Assignee: LIFEMINE THERAPEUTICS, INC.
    Inventors: John Baxter Biggins, Brian Roger Bowman, Gregory L. Verdine
  • HUMAN THERAPEUTIC TARGETS AND MODULATORS THEREOF
    Publication number: 20200211673
    Abstract: Among other things, the present disclosure provides technologies for efficient and effective identification of ETaGs, for example, from fungi genomes. In some embodiments, provided technologies are particularly useful for identifying mammalian targets of biosynthetic products of fungi. In some embodiments, provided technologies are particularly useful for identifying and/or prioritizing human targets for drug development. In some embodiments, provided technologies are particularly useful for developing modulators for human targets based on biosynthetic products of fungi.
    Type: Application
    Filed: September 14, 2018
    Publication date: July 2, 2020
    Inventors: John Baxter Biggins, Brian Roger Bowman, Gregory L. Verdine